tiprankstipranks
Trending News
More News >
Medexus Pharmaceuticals Inc (TSE:MDP)
TSX:MDP
Canadian Market

Medexus Pharmaceuticals Inc (MDP) Ratios

Compare
67 Followers

Medexus Pharmaceuticals Inc Ratios

TSE:MDP's free cash flow for Q2 2026 was C$0.56. For the 2026 fiscal year, TSE:MDP's free cash flow was decreased by C$ and operating cash flow was C$0.04. See a summary of the company’s cash flow.
Ratios
TTM
Dec 24Dec 23Dec 22Dec 21
Liquidity Ratios
Current Ratio
0.83 1.09 0.65 0.82 1.47
Quick Ratio
0.38 0.63 0.44 0.46 1.10
Cash Ratio
0.13 0.08 0.16 0.21 0.59
Solvency Ratio
0.10 0.04 0.05 0.03 -0.16
Operating Cash Flow Ratio
0.22 0.28 -0.01 -0.02 0.13
Short-Term Operating Cash Flow Coverage
0.78 1.19 -0.03 -0.06 0.38
Net Current Asset Value
C$ -34.59MC$ -52.91MC$ -114.73MC$ -102.71MC$ -71.92M
Leverage Ratios
Debt-to-Assets Ratio
0.14 0.32 0.59 0.39 0.38
Debt-to-Equity Ratio
0.40 1.65 4.22 3.08 3.13
Debt-to-Capital Ratio
0.29 0.62 0.81 0.76 0.76
Long-Term Debt-to-Capital Ratio
<0.01 0.53 0.54 0.69 0.65
Financial Leverage Ratio
2.85 5.14 7.19 7.83 8.24
Debt Service Coverage Ratio
0.58 0.65 0.31 0.52 -0.87
Interest Coverage Ratio
0.71 0.81 0.56 -1.23 -0.14
Debt to Market Cap
0.31 1.38 2.64 0.95 0.39
Interest Debt Per Share
0.86 2.83 5.42 3.45 4.38
Net Debt to EBITDA
0.72 2.32 4.77 2.79 -1.39
Profitability Margins
Gross Profit Margin
53.01%52.64%55.54%49.45%52.73%
EBIT Margin
6.94%11.91%7.92%10.96%-39.56%
EBITDA Margin
15.63%17.05%14.93%19.77%-29.63%
Operating Profit Margin
4.65%9.55%7.04%-19.55%-1.73%
Pretax Profit Margin
0.39%0.09%-4.66%-4.98%-39.54%
Net Profit Margin
0.37%-0.19%1.13%-3.75%-35.48%
Continuous Operations Profit Margin
0.37%-0.19%1.13%-3.75%-35.48%
Net Income Per EBT
93.15%-201.89%-24.22%75.37%89.72%
EBT Per EBIT
8.45%0.98%-66.21%25.47%2289.32%
Return on Assets (ROA)
0.25%-0.14%0.76%-2.07%-19.03%
Return on Equity (ROE)
0.80%-0.71%5.44%-16.18%-156.87%
Return on Capital Employed (ROCE)
6.50%12.06%15.70%-18.96%-1.27%
Return on Invested Capital (ROIC)
4.72%-20.71%-1.74%-11.55%-1.01%
Return on Tangible Assets
0.53%-0.26%1.51%-5.54%-45.96%
Earnings Yield
0.57%-0.60%3.82%-4.71%-23.54%
Efficiency Ratios
Receivables Turnover
8.62 4.70 3.64 5.32 3.37
Payables Turnover
1.30 6.91 4.73 2.57 2.53
Inventory Turnover
1.43 1.74 2.10 1.82 2.57
Fixed Asset Turnover
205.33 145.31 120.24 62.82 100.20
Asset Turnover
0.70 0.73 0.67 0.55 0.54
Working Capital Turnover Ratio
-7.66 -6.73 -4.25 20.18 6.50
Cash Conversion Cycle
16.58 234.53 196.65 127.78 106.61
Days of Sales Outstanding
42.35 77.58 100.27 68.56 108.43
Days of Inventory Outstanding
255.43 209.78 173.53 200.99 142.17
Days of Payables Outstanding
281.19 52.83 77.15 141.77 143.99
Operating Cycle
297.78 287.36 273.80 269.55 250.60
Cash Flow Ratios
Operating Cash Flow Per Share
0.50 0.84 -0.07 -0.06 0.33
Free Cash Flow Per Share
0.49 0.83 -0.09 -0.46 -0.38
CapEx Per Share
<0.01 0.01 0.02 0.40 0.71
Free Cash Flow to Operating Cash Flow
0.98 0.99 1.25 7.54 -1.13
Dividend Paid and CapEx Coverage Ratio
56.20 70.35 -3.99 -0.15 0.47
Capital Expenditure Coverage Ratio
56.20 70.35 -3.99 -0.15 0.47
Operating Cash Flow Coverage Ratio
0.77 0.38 -0.02 -0.02 0.09
Operating Cash Flow to Sales Ratio
0.16 0.17 -0.01 -0.02 0.06
Free Cash Flow Yield
23.59%51.33%-5.65%-14.56%-4.76%
Valuation Ratios
Price-to-Earnings (P/E) Ratio
176.65 -167.93 26.18 -21.22 -4.25
Price-to-Sales (P/S) Ratio
0.65 0.32 0.30 0.80 1.51
Price-to-Book (P/B) Ratio
1.28 1.19 1.42 3.43 6.66
Price-to-Free Cash Flow (P/FCF) Ratio
4.24 1.95 -17.70 -6.87 -21.00
Price-to-Operating Cash Flow Ratio
4.14 1.92 -22.13 -51.77 23.83
Price-to-Earnings Growth (PEG) Ratio
-4.00 1.50 -0.18 0.23 >-0.01
Price-to-Fair Value
1.28 1.19 1.42 3.43 6.66
Enterprise Value Multiple
4.87 4.18 6.76 6.82 -6.48
Enterprise Value
79.31M 80.58M 109.02M 103.42M 152.95M
EV to EBITDA
4.88 4.18 6.76 6.82 -6.48
EV to Sales
0.76 0.71 1.01 1.35 1.92
EV to Free Cash Flow
4.97 4.37 -60.36 -11.63 -26.75
EV to Operating Cash Flow
4.88 4.31 -75.50 -87.65 30.36
Tangible Book Value Per Share
-0.77 -1.98 -5.36 -5.13 -4.54
Shareholders’ Equity Per Share
1.62 1.36 1.12 0.91 1.19
Tax and Other Ratios
Effective Tax Rate
0.07 3.02 1.24 0.25 0.10
Revenue Per Share
3.22 5.06 5.41 3.94 5.24
Net Income Per Share
0.01 >-0.01 0.06 -0.15 -1.86
Tax Burden
0.93 -2.02 -0.24 0.75 0.90
Interest Burden
0.06 <0.01 -0.59 -0.45 1.00
Research & Development to Revenue
0.08 0.07 0.03 0.10 0.06
SG&A to Revenue
0.31 0.25 0.34 0.38 0.24
Stock-Based Compensation to Revenue
<0.01 <0.01 0.01 0.02 0.02
Income Quality
42.63 -87.45 -1.18 0.41 -0.18
Currency in CAD